Inventor
HIRST KIM LOUISE
GB16 patents
⚠️ This page may combine multiple inventors who share the name “HIRST KIM LOUISE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTEX THERAPEUTICS LTD
7 patentsUS10544132B2Jan 28, 2020
Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
ASTEX THERAPEUTICS LTD10 citations82
US10526311B2Jan 7, 2020
Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
ASTEX THERAPEUTICS LTD6 citations82
US11261171B1Mar 1, 2022
Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
ASTEX THERAPEUTICS LTD2 citations71
US10981898B2Apr 20, 2021
Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
ASTEX THERAPEUTICS LTD4 citations71
US11603367B2Mar 14, 2023
Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them
ASTEX THERAPEUTICS LTD2 citations66
US12071429B2Aug 27, 2024
Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
ASTEX THERAPEUTICS LTD0 citations60
US12077526B2Sep 3, 2024
Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them
ASTEX THERAPEUTICS LTD1 citations54
ANDREWS MARTIN JAMES INGLIS
4 patentsUS8178530B2May 15, 2012
Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
ANDREWS MARTIN JAMES INGLIS0 citations49
US8173656B2May 8, 2012
Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
ANDREWS MARTIN JAMES INGLIS0 citations49
US8148369B2Apr 3, 2012
Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases
ANDREWS MARTIN JAMES INGLIS0 citations47
US9006237B2Apr 14, 2015
Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases
ANDREWS MARTIN JAMES INGLIS0 citations45